Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1994 Oct;38(4):307-10.
doi: 10.1111/j.1365-2125.1994.tb04358.x.

Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm

Affiliations
Clinical Trial

Effect of NG-monomethyl-L-arginine on kinin-induced vasodilation in the human forearm

J R Cockcroft et al. Br J Clin Pharmacol. 1994 Oct.

Abstract

1. We compared effects of NG-monomethyl-L-arginine (L-NMMA), an NO synthase inhibitor, on vasodilator responses to intra-arterial infusion of bradykinin and substance P in the human forearm. 2. Bradykinin (100 pmol min-1) increased forearm blood flow when infused into the brachial artery of eight healthy male volunteers, from 2.8 +/- 0.2 (mean +/- s.e. mean) to 9.3 +/- 1.0 ml min-1 per 100 ml forearm volume. 3. Co-infusion of L-NMMA (2 mumol min-1 and 4 mumol min-1) with bradykinin (100 pmol min-1) for 6 min produced respectively a 9 +/- 14% and 42 +/- 14% inhibition (compared with L-NMMA vehicle) in the response to bradykinin. 4. Substance P (1 pmol min-1) when infused into the brachial artery of a further eight male subjects increased forearm blood flow from 3.4 +/- 0.2 to 6.3 +/- 0.7 ml min-1 100 ml-1. 5. Co-infusion of L-NMMA (2 mumol min-1 and 4 mumol min-1) with substance P (1 pmol min-1) for 6 min produced respectively a 27 +/- 8% and 70 +/- 13% inhibition (compared with L-NMMA vehicle) in the response to substance P. 6. These results demonstrate that vasodilator responses to both bradykinin and substance P are mediated in part via the L-arginine/NO pathway. Bradykinin and substance P may be useful agonists with which to study endothelial function in this vascular bed.

PubMed Disclaimer

References

    1. Pharmacol Rev. 1991 Jun;43(2):109-42 - PubMed
    1. Acta Physiol Scand. 1965 Mar;63:311-24 - PubMed
    1. Nature. 1980 Nov 27;288(5789):373-6 - PubMed
    1. Proc Natl Acad Sci U S A. 1982 Mar;79(6):2106-10 - PubMed
    1. Circ Res. 1983 Nov;53(5):557-73 - PubMed

Publication types

MeSH terms

LinkOut - more resources